EMA: COMMITTEE RECOMMENDED AUTHORISING PAXLOVID FOR TREATING COVID-19 IN ADULTS NOT REQUIRING SUPPLEMENTAL OXYGEN, AT INCREASED RISK OF DISEASE BECOMING SEVERE